AXDX insider transaction filings
Accelerate Diagnostics, Inc — 48 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-04-07. Screen AXDX transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for AXDX between 2026-06-25 and 2026-09-23. The table below lists the most recent filings on record.
Recent Form 4 filings — Accelerate Diagnostics, Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-04-07 | 4 | Mertz Larry Michael — Chief Technology Officer | Option exercise (M): 4,298 @ $0 · Sale (S): 1,523 @ $0.65 · Option exercise (M): 4,298 (derivative) @ $0 | EDGAR |
| 2025-04-07 | 4 | Phillips Jack — Chief Executive Officer, Director | Option exercise (M): 53,283 @ $0 · Sale (S): 25,343 @ $0.65 · Option exercise (M): 53,283 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Patience David — Chief Financial Officer | Option exercise (M): 20,000 @ $0 · Sale (S): 6,816 @ $0.71 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-27 | 4 | Patience David — Chief Financial Officer | Option exercise (M): 1,500 @ $0 · Sale (S): 535 @ $1.09 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Phillips Jack — Chief Executive Officer, Director | Option exercise (M): 1,000 @ $0 · Sale (S): 485 @ $1.35 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-12-03 | 4 | PATIENCE JOHN — Director | Purchase (P): 200,000 @ $1.57 | EDGAR |
| 2024-12-03 | 4 | SCHULER JACK W — Director, 10% owner | Sale (S): 200,000 @ $1.57 | EDGAR |
| 2024-07-01 | 4 | FRANCESCONI LOUISE — Director | Option exercise (M): 4,737 @ $0 · Option exercise (M): 4,737 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | MASSARANY HANY — Director | Option exercise (M): 4,737 @ $0 · Option exercise (M): 4,737 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | SCHULER JACK W — Director, 10% owner | Option exercise (M): 4,737 @ $0 · Option exercise (M): 4,737 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | BURRIS WAYNE — Director | Option exercise (M): 839 @ $0 · Option exercise (M): 839 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Regan Jennifer — Director | Option exercise (M): 7,894 @ $0 · Option exercise (M): 4,737 @ $0 · Option exercise (M): 7,894 (derivative) @ $0 · Option exercise (M): 4,737 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Patience David — Chief Financial Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Mertz Larry Michael — Chief Technology Officer | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | Phillips Jack — Chief Executive Officer, Director | Grant/award (A): 360,000 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | FRANCESCONI LOUISE — Director | Option exercise (M): 7,894 @ $0 · Option exercise (M): 7,894 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | MASSARANY HANY — Director | Option exercise (M): 7,894 @ $0 · Option exercise (M): 7,894 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | SCHULER JACK W — Director, 10% owner | Option exercise (M): 7,894 @ $0 · Option exercise (M): 7,894 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | SCHULER JACK W — Director, 10% owner | Grant/award (A): 1,560,694 · Grant/award (A): 1,560,694 (derivative) | EDGAR |
| 2024-05-21 | 4 | Black Mark S. — Director | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Regan Jennifer — Director | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Mertz Larry Michael — Chief Technology Officer | Option exercise (M): 1,000 @ $0 · Sale (S): 275 @ $0.88 · Option exercise (M): 283 @ $0 · Sale (S): 86 @ $0.88 · Option exercise (M): 1,000 (derivative) @ $0 · Option exercise (M): 283 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | BURRIS WAYNE — Director | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | Ogilvie Marran H. — Director | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | FRANCESCONI LOUISE — Director | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | MASSARANY HANY — Director | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | PATIENCE JOHN — Director | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | SCHULER JACK W — Director, 10% owner | Grant/award (A): 66,667 (derivative) @ $0 | EDGAR |
| 2024-04-18 | 4 | Phillips Jack — Chief Executive Officer, Director | Option exercise (M): 59,928 @ $0 · Sale (S): 26,735 @ $0.78 · Option exercise (M): 59,928 (derivative) @ $0 | EDGAR |
| 2024-04-16 | 4 | Phillips Jack — Chief Executive Officer, Director | Option exercise (M): 59,928 @ $0 · Sale (S): 26,545 @ $0.86 · Option exercise (M): 59,928 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | Patience David — Chief Financial Officer | Option exercise (M): 37,468 @ $0 · Sale (S): 13,296 @ $0.87 · Option exercise (M): 37,468 (derivative) @ $0 | EDGAR |
| 2024-04-10 | 4 | Mertz Larry Michael — Chief Technology Officer | Option exercise (M): 40,633 @ $0 · Sale (S): 13,984 @ $0.87 · Option exercise (M): 40,633 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Mertz Larry Michael — Chief Technology Officer | Option exercise (M): 2,866 @ $0 · Sale (S): 978 @ $0.88 · Option exercise (M): 2,866 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Phillips Jack — Chief Executive Officer, Director | Option exercise (M): 35,523 @ $0 · Sale (S): 15,887 @ $0.88 · Option exercise (M): 35,523 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Patience David — Chief Financial Officer | Grant/award (A): 37,468 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Mertz Larry Michael — Chief Technology Officer | Grant/award (A): 40,633 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Phillips Jack — Chief Executive Officer, Director | Grant/award (A): 119,856 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | Patience David — Chief Financial Officer | Option exercise (M): 1,000 @ $0 · Sale (S): 350 @ $0.96 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | Phillips Jack — Chief Executive Officer, Director | Option exercise (M): 1,000 @ $0 · Sale (S): 494 @ $1.30 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Patience David — Chief Financial Officer | Grant/award (A): 16,666 · Grant/award (A): 16,666 (derivative) | EDGAR |
| 2024-01-25 | 4 | Phillips Jack — Chief Executive Officer, Director | Grant/award (A): 16,666 · Grant/award (A): 16,666 (derivative) | EDGAR |
| 2024-01-25 | 4 | Strobeck Matthew — Director | Purchase (P): 100,000 · Purchase (P): 100,000 (derivative) | EDGAR |
| 2024-01-25 | 4 | FRANCESCONI LOUISE — Director | Purchase (P): 13,333 · Purchase (P): 13,333 (derivative) | EDGAR |
| 2024-01-25 | 4 | MASSARANY HANY — Director | Purchase (P): 16,666 · Purchase (P): 16,666 (derivative) | EDGAR |
| 2024-01-25 | 4 | PATIENCE JOHN — Director | Purchase (P): 16,666 · Purchase (P): 16,666 (derivative) | EDGAR |
| 2024-01-25 | 4 | SCHULER JACK W — Director, 10% owner | Grant/award (A): 1,156,069 · Grant/award (A): 1,156,069 (derivative) | EDGAR |
| 2023-12-14 | 4 | Patience David — Chief Financial Officer | Option exercise (M): 331 @ $0 · Sale (S): 97 @ $4.39 · Option exercise (M): 331 (derivative) @ $0 | EDGAR |
| 2023-12-14 | 4 | Phillips Jack — Chief Executive Officer, Director | Option exercise (M): 1,721 @ $0 · Sale (S): 739 @ $4.39 · Option exercise (M): 1,721 (derivative) @ $0 | EDGAR |
Recent 8-K events — Accelerate Diagnostics, Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-08-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.03 — Bankruptcy or Receivership 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-05-12 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-05-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.03 — Bankruptcy or Receivership 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-04-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-03-21 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-30 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AXDX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →